Cost‐effectiveness of measles outbreak intervention strategies
暂无分享,去创建一个
[1] A. Herceg,et al. An outbreak of measles in a highly immunised population: immunisation status and vaccine efficacy. , 2010, Australian journal of public health.
[2] P. Hawe. Measles control: a best-practice challenge in public health. , 2010, Australian journal of public health.
[3] T. Miles,et al. An outbreak of measles in the Hunter area of New South Wales. , 2010, Australian journal of public health.
[4] D. Christie,et al. Measles immunisation compliance: poor impact of bicentennial measles control campaigns on children under five. , 2010, Australian journal of public health.
[5] P. Bazeley. Public and private immunisation services: a comparison of costs. , 2010, Community health studies.
[6] D. Fleming,et al. An evaluation of measles revaccination among school-entry-aged children. , 1996, Pediatrics.
[7] A. Corriveau,et al. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles. , 1996, Pediatrics.
[8] E. Mendelson,et al. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel , 1995, The Pediatric infectious disease journal.
[9] Louisa R Jorm,et al. Measles outbreak in western Sydney: Vaccine failure or failure to vaccinate? , 1995, The Medical journal of Australia.
[10] G. Kearns,et al. Measles: an historical geography of a major human viral disease from global expansion to local retreat, 1840–1990 , 1995, Medical History.
[11] De Silva Lm,et al. Measles susceptibility under one year of age and vaccination strategy. , 1994 .
[12] L. De Silva,et al. Measles susceptibility under one year of age and vaccination strategy , 1994, The Medical journal of Australia.
[13] A Briggs,et al. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. , 1994, Health economics.
[14] A. Scott,et al. The value of early discharge: dispelling some myths. , 1993, Health policy.
[15] T. Chey,et al. The epidemiology of incomplete childhood immunization: An analysis of reported immunization status in outer western Sydney , 1993, Journal of paediatrics and child health.
[16] N. Pollock,et al. Propofol is a ‘Safe’ Anaesthetic Agent in Malignant Hyperthermia Susceptible Patients , 1992 .
[17] T. Tulchinsky,et al. Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza. , 1990, Journal of epidemiology and community health.
[18] E. Mast,et al. Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies. , 1990, JAMA.
[19] P. Mead,et al. A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure. , 1990, American journal of epidemiology.
[20] M. Burgess,et al. Optimal age for measles and mumps vaccination in Australia , 1990, The Medical journal of Australia.
[21] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[22] A. Hinman,et al. A cost-effectiveness analysis of measles outbreak control strategies. , 1987, American journal of epidemiology.
[23] L. Sehulster,et al. Measles outbreak in a fully immunized secondary-school population. , 1987, The New England journal of medicine.
[24] S. Leeder,et al. Costs, Severity of Illness and Outcome in Intensive Care , 1986, Anaesthesia and intensive care.
[25] F. Black,et al. Maternally derived measles immunity in era of vaccine-protected mothers. , 1986, The Journal of pediatrics.
[26] P. Mitchell,et al. The development of performance and cost indicators for preschool immunisation. , 1986, Archives of disease in childhood.
[27] J. Koplan,et al. Benefits, risks and costs of immunization for measles, mumps and rubella. , 1985, American journal of public health.
[28] E. Zell,et al. Outbreaks in highly vaccinated populations: implications for studies of vaccine performance. , 1994, American journal of epidemiology.
[29] Louisa Jorm,et al. Measles epidemic in Western Sydney , 1994 .
[30] T. Tulchinsky,et al. Measles control in developing and developed countries: the case for a two-dose policy. , 1993, Bulletin of the World Health Organization.
[31] Expanded programme on immunization. An estimate of measles vaccine efficacy in a Canberra primary school. , 1993, Releve epidemiologique hebdomadaire.
[32] F. Cutts,et al. The epidemiology of measles. , 1992, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[33] S. Robertson,et al. A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy. , 1992, Public health reports.
[34] B. McNeil,et al. Decision analysis for public health: principles and illustrations. , 1984, Annual review of public health.
[35] R. Albritton,et al. Cost-benefits of measles eradication: effects of a federal intervention. , 1978, Policy analysis.
[36] J. McCormick,et al. Measles vaccine efficacy determined from secondary attack rates during a severe epidemic. , 1977, The Journal of pediatrics.